1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Non-alcoholic Fatty Liver Disease

1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, CJ; Fang, CC; Hsiao, HH; Hsiao, HP; Kant, R; Lin, KJ; Lu, CK; Nguyen, HM; Yen, CH	1

Other Studies

1 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Non-alcoholic Fatty Liver Disease

Article	Year
1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 129 Topics: Animals; Biomarkers; Blood Glucose; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation; Homeostasis; Hydrolyzable Tannins; Lipid Metabolism; Lipids; Liver; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease	2020

Article

Year

1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 129

Topics: Animals; Biomarkers; Blood Glucose; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation; Homeostasis; Hydrolyzable Tannins; Lipid Metabolism; Lipids; Liver; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease

2020